论文部分内容阅读
目的探讨吡喹酮诊断性治疗在疑似脑囊尾蚴病中的应用价值。方法收集疑似脑囊尾蚴病病例进行诊断性治疗,以吡喹酮50 mg/(kg·d),分3次服用,每个疗程10~12天,治疗3~5个疗程,并进行1~2年的随访观察,评价疗效。结果共收集到94例疑似脑囊尾蚴病病例,其中78例(占82.98%)经诊断性治疗确诊为脑囊尾蚴病,13例(占13.83%)排除脑囊尾蚴病可能,另外3例(3.19%)未能明确诊断。结论吡喹酮诊断性治疗能减少非典型脑囊尾蚴病患者的漏诊和误诊。
Objective To investigate the value of praziquantel in the diagnosis of cerebral cysticercosis. Methods Suspected cerebral cysticercosis cases were collected for diagnostic treatment. Praziquantel 50 mg / (kg · d) was given in 3 doses for 10 ~ 12 days for 3 ~ 5 courses of treatment and 1 ~ 2 years of follow-up observation, evaluation of efficacy. Results A total of 94 cases of suspected cysticercosis were collected, of which 78 cases (82.98%) were diagnosed as cerebral cysticercosis by diagnostic treatment, 13 cases (13.83%) were excluded from the cerebral cysticercosis, the other 3 cases ( 3.19%) failed to confirm the diagnosis. Conclusion The praziquantel diagnostic treatment can reduce the missed diagnosis and misdiagnosis of patients with atypical cerebral cysticercosis.